![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 21, 2002
Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800
Corresponding Author: steve.ralph{at}med.monash.edu.au
The transcription factor STAT1 plays a pivotal role in signal transduction of type I and II IFNs. STAT1 activation leads to changes in expression of key regulatory genes encoding caspases and cell cycle inhibitors. Deficient STAT1 expression in human cancer cells and viral mediated inhibition of STAT1 function has been associated with cellular resistance to IFNs and mycobacterial infection in humans. Thus, given the relative importance of STAT1, we isolated and characterised a human STAT1 intronic enhancer region displaying IFN regulated activity. Functional analyses by transient expression identified a repressor region and type I and II IFN-inducible elements within the STAT1 enhancer sequence. A candidate IRF-E/GAS/IRF-E (IGI) sequence containing GAAANN nucleotide repeats was shown by gel shift assay to bind to IRF-1 but not to ISGF3 or STATs 1-3. An additional larger IGI binding complex containing IRF-1 was identified. Mutation of the GAAANN repeats within the IGI DNA element eliminated IRF-1 binding and the IFN regulated activity of the STAT1 intronic enhancer region. Transfection of the IFN-resistant MM96 cell line to express increased levels of IRF-1 protein also elevated STAT1, STAT2 and p48/IRF-9 expression and enhanced cellular responsiveness to IFN
J. Biol. Chem, 10.1074/jbc.M111302200
Submitted on November 27, 2001
Revised on March 13, 2002
Accepted on March 20, 2002
Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by IFN types I and II and role of IRF-1
. Reciprocating regulation between IRF-1 and STAT1 genes and encoded proteins indicates that an intracellular amplifier circuit exists controlling cellular responsiveness to the IFNs.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Smieja, M. Jamaluddin, A. R. Brasier, and M. Kimmel Model-based analysis of interferon-{beta} induced signaling pathway Bioinformatics, October 15, 2008; 24(20): 2363 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumiya, S. M. Prescott, and D. M. Stafforini IFN-{epsilon} Mediates TNF-{alpha}-Induced STAT1 Phosphorylation and Induction of Retinoic Acid-Inducible Gene-I in Human Cervical Cancer Cells J. Immunol., October 1, 2007; 179(7): 4542 - 4549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Arakura, S. Hida, E. Ichikawa, C. Yajima, S. Nakajima, T. Saida, and S. Taki Genetic Control Directed toward Spontaneous IFN-{alpha}/IFN-beta Responses and Downstream IFN-{gamma} Expression Influences the Pathogenesis of a Murine Psoriasis-Like Skin Disease J. Immunol., September 1, 2007; 179(5): 3249 - 3257. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-W. Chang, B. R. Fontaine, G. D. Stormo, and R. Nagarajan PAP: a comprehensive workbench for mammalian transcriptional regulatory sequence analysis Nucleic Acids Res., July 13, 2007; 35(suppl_2): W238 - W244. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Stout, K. Melendez, J. Seagrave, M. J. Holtzman, B. Wilson, J. Xiang, and Y. Tesfaigzi STAT1 Activation Causes Translocation of Bax to the Endoplasmic Reticulum during the Resolution of Airway Mucous Cell Hyperplasia by IFN-{gamma} J. Immunol., June 15, 2007; 178(12): 8107 - 8116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-W. Chang, R. Nagarajan, J. A. Magee, J. Milbrandt, and G. D. Stormo A systematic model to predict transcriptional regulatory mechanisms based on overrepresentation of transcription factor binding profiles Genome Res., March 1, 2006; 16(3): 405 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Kramer, D. Baus, S. K. Knauer, S. Stein, E. Jager, R. H. Stauber, M. Grez, E. Pfitzner, and T. Heinzel Acetylation of Stat1 modulates NF-{kappa}B activity. Genes & Dev., February 15, 2006; 20(4): 473 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sironi, G. Menozzi, G. P. Comi, R. Cagliani, N. Bresolin, and U. Pozzoli Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences Hum. Mol. Genet., September 1, 2005; 14(17): 2533 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imaizumi, M. Kumagai, K. Taima, T. Fujita, H. Yoshida, and K. Satoh Involvement of retinoic acid-inducible gene-I in the IFN-{gamma}/STAT1 signalling pathway in BEAS-2B cells Eur. Respir. J., June 1, 2005; 25(6): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, M. Chatterjee-Kishore, S. M. Staugaitis, H. Nguyen, K. Schlessinger, D. E. Levy, and G. R. Stark Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation Cancer Res., February 1, 2005; 65(3): 939 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bai and J. L. Merchant Transcription factor ZBP-89 is required for STAT1 constitutive expression Nucleic Acids Res., December 15, 2003; 31(24): 7264 - 7270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klampfer, J. Huang, G. Corner, J. Mariadason, D. Arango, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ki-Ras Inhibits the Expression of Interferon-responsive Genes through Inhibition of STAT1 and STAT2 Expression J. Biol. Chem., November 21, 2003; 278(47): 46278 - 46287. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Roberts, M. A. Zandonatti, D. D. Watry, L. J. Madden, S. J. Henriksen, M. A. Taffe, and H. S. Fox Induction of Pathogenic Sets of Genes in Macrophages and Neurons in NeuroAIDS Am. J. Pathol., June 1, 2003; 162(6): 2041 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, W.-P. Li, C. Meng, and L. B. Ivashkiv Inhibition of IFN-{gamma} Signaling by Glucocorticoids J. Immunol., May 1, 2003; 170(9): 4833 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Durda, I. S. Dunn, L. B. Rose, D. Butera, E. M. Benson, F. Pandolfi, and J. T. Kurnick Induction of "Antigen Silencing" in Melanomas by Oncostatin M: Down-Modulation of Melanocyte Antigen Expression Mol. Cancer Res., April 1, 2003; 1(6): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |